US Edition
News from Stemwell Science News
Information about Stemwell Science News
Where is Stemwell Science News located?Stemwell Science News's WebsiteStemwell Science News's TwitterMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Stemwell Science News News
Medical · CincinnatiA study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist treatment and points to potential new combination therapies to make treatments more effective.See the Story
Cellular targets to overcome KRAS inhibitor resistance in pancreatic tumors identified
100% Center coverage: 1 sources
United States · United StatesOncolytics Biotech®, Inc. announced alignment with the US FDA regarding the design of its pivotal study of pelareorep in combination with standard-of-care therapy for the first-line treatment of metastatic pancreatic ductal adenocarcinoma. [Oncolytics Biotech®, Inc.] Press ReleaseSee the Story
Oncolytics Biotech® Aligns with FDA on Pivotal Study Design for Pelareorep in First-Line Pancreatic Cancer
